Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Kodiak Sciences Inc

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic retinal diseases. The company's proprietary platform focuses on developing longer-lasting treatments for conditions like wet age-related macular degeneration and diabetic retinopathy. Kodiak's lead product candidate is designed to reduce treatment burden through extended dosing intervals.